0.00Open0.15Pre Close0 Volume39 Open Interest22.50Strike Price0.00Turnover123.92%IV25.48%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.2368Delta0.0660Gamma31.39Leverage Ratio-0.0457Theta0.0016Rho7.43Eff Leverage0.0116Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet